Sun Yat-sen University Cancer Center (SYSUCC) was established in 1964 and is one of the four earliest tumor hospitals in China. It is one of the affiliated hospitals of the prestigious Sun Yat-sen University. Located in the city of Guangzhou, SYSUCC is leading the way on a national frontier. It is the largest integrated cancer center in the whole of southern China for cancer care, education, research and prevention. SYSUCC’s mission is to help people prevent and cure cancer.
SYSUCC has been awarded many prestigious titles over the years:
* National Key Disciplines (Oncology)
* State Key Laboratory (SKL) of Oncology in South China
* Key Laboratory of Oncology of the Ministry of Education
* Key Laboratory of Guangdong Province
* National Clinical Study Center for Anticancer Drugs
* Cancer Hospital of Chinese Traditional and Western Medicine
* Doctoral Degree Authorization Center
* Post-doctoral Station of Scientific Research
SYSUCC is also a supporting institute for the Guangdong Cancer Center, the Guangdong Esophageal Cancer Research Institute and the Guangdong Anti-cancer Association.
SYSUCC never stops improving its quality of service pushing the boundaries of research and patient care. The responsibility system of the chief expert for a single cancer disease was first applied in our center and the multi-disciplinary diagnosis and treatment plan for different cancer diseases were designed by our specialists. Under the effort of the physicians and nurses at SYSUCC, 61 clinical research achievements have been adopted by international treatment guidelines since 2015.
SYSUCC currently has two operational campuses with a third pending. The first campus is located in the Yuexiu district of Guangzhou city and the second campus is in Huangpu district and a third planned in Tianhe district.
SYSUCC has a comprehensive range of medical departments and centers at both campuses, unless stated otherwise:
Bone and Soft Tissue Surgery (Huangpu Campus only)
Cancer Prevention Research
Clinical Trial Center
Head and Neck Surgery
Hematological Oncology (Huangpu Campus only)
Intensive Care Unit
Minimally Invasive Therapy
Molecular Diagnosis (Huangpu Campus only)
Pancreaticobiliary Surgery (Huangpu Campus only)
Screening Center for Cancer Prevention
Traditional Chinese Medicine
Ultrasound and Electrocardiogram
The Yuexiu campus is a modern medical service provider with 1,600 ward beds, 34 clinical departments, 8 administrative offices and 2 research departments. Equipped with state of the art medical technology, it has a premier radiation therapy center and two da Vinci robots (one at each campus) for minimally invasive surgeries. The campus provides a comprehensive range of health care services for cancer diagnosis and treatment including surgery, radiotherapy, chemotherapy, interventional therapy, immunotherapy, and Traditional Chinese Medicine (TCM).
The Radiation Center at the Yuexiu campus has 13 Linear Accelerators and 14 Treatment Rooms. Together, the team treat over a 1,000 patients each day. The site has been equipped with the following technologies since 2010: IGRT, VMAT and SBRT Technologies, in addition to the existing 3DCRT, IMRT and 4 DCT.
Research and New Drug Development
As one of the earliest cancer hospitals founded in China, SYSUCC has always closely combined its clinical and research attributes, ranking top two in the Chinese Hospital of Scientific Impact Ranking. The State Key Laboratory (SKL) of Oncology in South China was founded in March 2005 by the Ministry of Science and Technology in China. This laboratory is jointly operates out of the Yuexiu and Huangpu campuses. Its activities cover a broad spectrum in oncology from basic to translational and clinical research.
Since 2001, a tumor tissue bank has been established at the Yuexiu site to provide researchers with a dynamic collection of biological samples (blood, fresh tissue, bone marrow, biopsy and other fluids) for cancer research. To help bridge the gap between basic drug research and clinical applications, a Clinical Trial Center (CTC) was also setup to assist physicians and scientists to test new therapies. It includes a National Clinical Study Center for Anticancer Drugs and a National Key Laboratory of Anti-cancer Drug Development. The CTC is China Food and Drug Administration (CFDA) certified. Its core services range from clinical research management, Phase I research, medical statistics, academic research consultation, clinical trial regulation and technical guideline training, feasibility assessment and investigator identification, regulatory affairs, finance and contract management, data management, and clinical epidemiology.
In order to achieve SYSUCC’s strategic goal of offering the largest scale and the highest level of health care services, while developing the most complete scope of specialties, the new Huangpu Campus was built with the approval of the National Health Commission of the People’s Republic of China, as an important step in the cancer center becoming a world-class institute.
The Huangpu Campus is located in the southern area of the Sino-Singapore Guangzhou Knowledge City. The campus’s design reflects the ideas of "humanization, ecology and modernization", and introduces the spatial concept of "street" into its design as part of its appeal attract outstanding talent. The Knowledge City is part of the national strategy of innovation - a new engine to lead the industrial transformation and the development of the Pearl River Delta in Guangdong province and China. The area has a world-class ecological landscape where industry, environment and society complement each other harmoniously.
The construction project started in November 2016 and the main structure was completed in June 2018, with its trial opening in February 2021. The center was officially opened in March 2021. The metro, bus and expressway are all connected to different parts of the cancer center’s campus. With quick access to the city center, train station and airport, enabling patients from all over the world to come to the center.
After the first period of construction, the 894.2 million CNY investment yielded a 104,828 square meter campus and a 500 hospital bed facility. The departments of Head and Neck surgery, Thoracic Surgery, Pancreaticobiliary Surgery, Colorectal Surgery, Gastric Surgery, Urology, Breast Cancer, Medical Oncology, Radiation Oncology, Nasopharyngeal Carcinoma, Hematological Oncology, Bone and Soft Tissue Surgery, Invasive Therapy, and others are housed there to meet the needs of different cancer patients along with a logistics service center to help provide a greater and more efficient public medical platform.
The Huangpu Campus also includes the State Key Laboratory of Oncology in South China, the State Key Discipline of Oncology and the National Clinical Trials Center for New Drugs (anti-cancer drugs), with their strengths in basic and clinical research. Through the new facilities, the specialties of thoracic cancer, gastrointestinal cancer, lymphoma and head and neck tumors (including nasopharyngeal carcinoma) will be developed to international standards, and the specialties of breast cancer, genitourinary tumor, bone and soft tissue tumor to national standards. At the same time, translational research will support the scientific and technological innovation.
Medical services including the molecular diagnostic laboratory of oncology which was built for the clinical application of targeted anti-tumor drugs and individualized treatment of pediatric neuroblastoma, and the laboratory and laminar flow aseptic ward of hematological tumors will also enable specialists to carry out allogeneic bone marrow transplantation. Surgical robots, cyclotron and other advanced medical equipment will further enhance the comprehensive strength of the cancer center in all aspects of medical education and research. In collaboration with the neighboring Guangzhou Concord Cancer Center, the Huangpu Campus also provides proton therapy to meet patients’ special needs.
In 2003, SYSUCC became a sister institution of the University of Texas MD Anderson Cancer Center (MDACC) -- a top-ranking cancer research institute and hospital in the United States. SYSUCC also has numerous international partners all around the world, including the Netherlands Cancer Institute (NKI), Karolinska Institutet, the University of Warwick, Fred Hutchinson and the Erasmus Medical Center. Together, we combine different approaches as part of the same goal in our fight to conquer cancer. SYSUCC has also been a longstanding UICC member since.
Updated March 2021